Alpeche, Cris .
HRN: 19-03-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2023
METRONIDAZOLE 500MG (TAB)
09/28/2023
10/04/2023
ORAL
500mg
Tid
Thickly MSAF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes